Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It?

Richard B. Thomson; Erin McElvania

doi:10.1016/j.cll.2019.05.002

Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It?

Richard B. Thomson, Erin McElvania

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

The first clinical microbiology laboratory in the United States adopted total automation for bacteriology processing in 2014. Since then, others have followed with installation of either the BD Kiestra TLA or the Copan WASPLab. This article discusses commercially available automated systems in the United States; why automation is needed; and quality improvements, efficiency, and cost savings associated with automation. After learning how these systems are used, gains and losses experienced, and how one can afford the most expensive equipment ever purchased for clinical microbiology laboratories, the question is, how can one afford not to purchase one of these microbiology automation systems?

Original language	English (US)
Pages (from-to)	371-389
Number of pages	19
Journal	Clinics in laboratory medicine
Volume	39
Issue number	3
DOIs	https://doi.org/10.1016/j.cll.2019.05.002
State	Published - Sep 2019
Externally published	Yes

Keywords

BD Kiestra TLA
Copan WASPLab
Microbiology automation
Microbiology cost savings
Microbiology efficiency
Microbiology quality

ASJC Scopus subject areas

Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1016/j.cll.2019.05.002

Cite this

@article{66a9407899a646dd984a96443c26dabe,

title = "Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It?",

abstract = "The first clinical microbiology laboratory in the United States adopted total automation for bacteriology processing in 2014. Since then, others have followed with installation of either the BD Kiestra TLA or the Copan WASPLab. This article discusses commercially available automated systems in the United States; why automation is needed; and quality improvements, efficiency, and cost savings associated with automation. After learning how these systems are used, gains and losses experienced, and how one can afford the most expensive equipment ever purchased for clinical microbiology laboratories, the question is, how can one afford not to purchase one of these microbiology automation systems?",

keywords = "BD Kiestra TLA, Copan WASPLab, Microbiology automation, Microbiology cost savings, Microbiology efficiency, Microbiology quality",

author = "Thomson, {Richard B.} and Erin McElvania",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = sep,

doi = "10.1016/j.cll.2019.05.002",

language = "English (US)",

volume = "39",

pages = "371--389",

journal = "Clinics in laboratory medicine",

issn = "0272-2712",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Total Laboratory Automation

T2 - What Is Gained, What Is Lost, and Who Can Afford It?

AU - Thomson, Richard B.

AU - McElvania, Erin

PY - 2019/9

Y1 - 2019/9

N2 - The first clinical microbiology laboratory in the United States adopted total automation for bacteriology processing in 2014. Since then, others have followed with installation of either the BD Kiestra TLA or the Copan WASPLab. This article discusses commercially available automated systems in the United States; why automation is needed; and quality improvements, efficiency, and cost savings associated with automation. After learning how these systems are used, gains and losses experienced, and how one can afford the most expensive equipment ever purchased for clinical microbiology laboratories, the question is, how can one afford not to purchase one of these microbiology automation systems?

AB - The first clinical microbiology laboratory in the United States adopted total automation for bacteriology processing in 2014. Since then, others have followed with installation of either the BD Kiestra TLA or the Copan WASPLab. This article discusses commercially available automated systems in the United States; why automation is needed; and quality improvements, efficiency, and cost savings associated with automation. After learning how these systems are used, gains and losses experienced, and how one can afford the most expensive equipment ever purchased for clinical microbiology laboratories, the question is, how can one afford not to purchase one of these microbiology automation systems?

KW - BD Kiestra TLA

KW - Copan WASPLab

KW - Microbiology automation

KW - Microbiology cost savings

KW - Microbiology efficiency

KW - Microbiology quality

UR - http://www.scopus.com/inward/record.url?scp=85071148739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071148739&partnerID=8YFLogxK

U2 - 10.1016/j.cll.2019.05.002

DO - 10.1016/j.cll.2019.05.002

M3 - Review article

C2 - 31383263

AN - SCOPUS:85071148739

SN - 0272-2712

VL - 39

SP - 371

EP - 389

JO - Clinics in laboratory medicine

JF - Clinics in laboratory medicine

IS - 3

ER -

Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this